Skip to main content
Erschienen in: Der Nervenarzt 4/2017

01.03.2017 | Parkinson-Krankheit | Leitthema

Nichtmedikamentöse Therapieverfahren beim Morbus Parkinson

verfasst von: Prof. Dr. K. Witt, E. Kalbe, R. Erasmi, G. Ebersbach

Erschienen in: Der Nervenarzt | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Zusammenfassung

Nichtmedikamentöse Therapien zur Behandlung der Parkinson-Erkrankung beinhalten Physio-, Ergotherapie, Logopädie, kognitive Trainingsverfahren sowie die tiefe Hirnstimulation und nichtinvasive Hirnstimulationsverfahren. Mit der Diagnose der Parkinson-Krankheit können aktivierende Therapien, wie die Bewegungstherapien und die Logopädie – angepasst an das Symptomprofil des Patienten, – hilfreich sein. Milde kognitive Beeinträchtigungen sind häufig im Verlauf der Parkinson-Erkrankung messbar und ein Progress dieser Störungen bis hin zu einer demenziellen Entwicklung im fortgeschrittenen Krankheitsstadium ist nicht selten. Wann ein kognitives Training empfohlen werden kann und mit welcher Trainingsmethodik und Häufigkeit dieses angewendet werden sollte, ist Gegenstand aktueller Forschung. Die tiefe Hirnstimulation ist ein etabliertes Verfahren, welches dann in Erwägung gezogen werden sollte, wenn hinderliche motorische Fluktuationen durch medikamentöse Therapiemöglichkeiten nicht ausreichend behandelt werden können. Diese Therapieform ist zudem an spezifische patientenorientierte Bedingungen geknüpft und bedarf der Abstimmung in einem multiprofessionellen Team. Nichtinvasive Stimulationstechniken beinhalten die repetitive transkranielle Magnetstimulation und die transkranielle Gleichstromstimulation, welche experimentelle Therapiemodalitäten darstellen und außerhalb von Studienprotokollen derzeit nicht empfohlen werden können.
Literatur
1.
Zurück zum Zitat Bloem BR, de Vries NM, Ebersbach G (2015) Nonpharmacological treatments for patients with Parkinson’s disease. Mov Disord 30(11):1504–1520CrossRefPubMed Bloem BR, de Vries NM, Ebersbach G (2015) Nonpharmacological treatments for patients with Parkinson’s disease. Mov Disord 30(11):1504–1520CrossRefPubMed
2.
Zurück zum Zitat Bloem BR, Grimbergen YA, Cramer M, Willemsen M, Zwinderman AH (2001) Prospective assessment of falls in Parkinson’s disease. J Neurol 248(11):950–958CrossRefPubMed Bloem BR, Grimbergen YA, Cramer M, Willemsen M, Zwinderman AH (2001) Prospective assessment of falls in Parkinson’s disease. J Neurol 248(11):950–958CrossRefPubMed
3.
Zurück zum Zitat Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord 23(6):837–844CrossRefPubMed Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord 23(6):837–844CrossRefPubMed
4.
Zurück zum Zitat Petzinger GM, Fisher BE, McEwen S, Beeler JA, Walsh JP, Jakowec MW (2013) Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson’s disease. Lancet Neurol 12(7):716–726CrossRefPubMedPubMedCentral Petzinger GM, Fisher BE, McEwen S, Beeler JA, Walsh JP, Jakowec MW (2013) Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson’s disease. Lancet Neurol 12(7):716–726CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Sehm B, Taubert M, Conde V, Weise D, Classen J, Dukart J, Draganski B, Villringer A, Ragert P (2014) Structural brain plasticity in Parkinson’s disease induced by balance training. Neurobiol Aging 35(1):232–239CrossRefPubMed Sehm B, Taubert M, Conde V, Weise D, Classen J, Dukart J, Draganski B, Villringer A, Ragert P (2014) Structural brain plasticity in Parkinson’s disease induced by balance training. Neurobiol Aging 35(1):232–239CrossRefPubMed
6.
Zurück zum Zitat Frazzitta G, Maestri R, Ghilardi MF, Riboldazzi G, Perini M, Bertotti G, Boveri N, Buttini S, Lombino FL, Uccellini D et al (2014) Intensive rehabilitation increases BDNF serum levels in Parkinsonian patients: a randomized study. Neurorehabil Neural Repair 28(2):163–168CrossRefPubMed Frazzitta G, Maestri R, Ghilardi MF, Riboldazzi G, Perini M, Bertotti G, Boveri N, Buttini S, Lombino FL, Uccellini D et al (2014) Intensive rehabilitation increases BDNF serum levels in Parkinsonian patients: a randomized study. Neurorehabil Neural Repair 28(2):163–168CrossRefPubMed
7.
Zurück zum Zitat Ceballos-Baumann A, Ebersbach G (2013) Aktivierende Therapie bei Parkinson-Syndromen, 2. Aufl. Thieme, Stuttgart Ceballos-Baumann A, Ebersbach G (2013) Aktivierende Therapie bei Parkinson-Syndromen, 2. Aufl. Thieme, Stuttgart
8.
Zurück zum Zitat Clarke CE, Walker MF, Sackley CM (2016) Physiotherapy and occupational therapy and mild to moderate Parkinson disease-reply. JAMA Neurol 73(7):894–895CrossRefPubMed Clarke CE, Walker MF, Sackley CM (2016) Physiotherapy and occupational therapy and mild to moderate Parkinson disease-reply. JAMA Neurol 73(7):894–895CrossRefPubMed
9.
Zurück zum Zitat Fox C, Ebersbach G, Ramig L, Sapir S (2012) LSVT LOUD and LSVT BIG: behavioral treatment programs for speech and body movement in Parkinson disease. Parkinsons Dis 2012:391946PubMedPubMedCentral Fox C, Ebersbach G, Ramig L, Sapir S (2012) LSVT LOUD and LSVT BIG: behavioral treatment programs for speech and body movement in Parkinson disease. Parkinsons Dis 2012:391946PubMedPubMedCentral
10.
Zurück zum Zitat Ebersbach G, Ebersbach A, Edler D, Kaufhold O, Kusch M, Kupsch A, Wissel J (2010) Comparing exercise in Parkinson’s disease – the Berlin BIG study. Mov Disord 25(12):1902–1908CrossRefPubMed Ebersbach G, Ebersbach A, Edler D, Kaufhold O, Kusch M, Kupsch A, Wissel J (2010) Comparing exercise in Parkinson’s disease – the Berlin BIG study. Mov Disord 25(12):1902–1908CrossRefPubMed
11.
Zurück zum Zitat Shanahan J, Morris ME, Bhriain ON, Saunders J, Clifford AM (2015) Dance for people with Parkinson disease: what is the evidence telling us? Arch Phys Med Rehabil 96(1):141–153CrossRefPubMed Shanahan J, Morris ME, Bhriain ON, Saunders J, Clifford AM (2015) Dance for people with Parkinson disease: what is the evidence telling us? Arch Phys Med Rehabil 96(1):141–153CrossRefPubMed
12.
Zurück zum Zitat Spaulding SJ, Barber B, Colby M, Cormack B, Mick T, Jenkins ME (2013) Cueing and gait improvement among people with Parkinson’s disease: a meta-analysis. Arch Phys Med Rehabil 94(3):562–570CrossRefPubMed Spaulding SJ, Barber B, Colby M, Cormack B, Mick T, Jenkins ME (2013) Cueing and gait improvement among people with Parkinson’s disease: a meta-analysis. Arch Phys Med Rehabil 94(3):562–570CrossRefPubMed
13.
Zurück zum Zitat Li F, Harmer P, Fitzgerald K, Eckstrom E, Stock R, Galver J, Maddalozzo G, Batya SS (2012) Tai chi and postural stability in patients with Parkinson’s disease. N Engl J Med 366(6):511–519CrossRefPubMedPubMedCentral Li F, Harmer P, Fitzgerald K, Eckstrom E, Stock R, Galver J, Maddalozzo G, Batya SS (2012) Tai chi and postural stability in patients with Parkinson’s disease. N Engl J Med 366(6):511–519CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Rochester L, Baker K, Hetherington V, Jones D, Willems AM, Kwakkel G, van Wegen E, Lim I, Nieuwboer A (2010) Evidence for motor learning in Parkinson’s disease: acquisition, automaticity and retention of cued gait performance after training with external rhythmical cues. Brain Res 1319:103–111CrossRefPubMed Rochester L, Baker K, Hetherington V, Jones D, Willems AM, Kwakkel G, van Wegen E, Lim I, Nieuwboer A (2010) Evidence for motor learning in Parkinson’s disease: acquisition, automaticity and retention of cued gait performance after training with external rhythmical cues. Brain Res 1319:103–111CrossRefPubMed
15.
Zurück zum Zitat Jobges M, Heuschkel G, Pretzel C, Illhardt C, Renner C, Hummelsheim H (2004) Repetitive training of compensatory steps: a therapeutic approach for postural instability in Parkinson’s disease. J Neurol Neurosurg Psychiatr 75(12):1682–1687CrossRefPubMedPubMedCentral Jobges M, Heuschkel G, Pretzel C, Illhardt C, Renner C, Hummelsheim H (2004) Repetitive training of compensatory steps: a therapeutic approach for postural instability in Parkinson’s disease. J Neurol Neurosurg Psychiatr 75(12):1682–1687CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Herd CP, Tomlinson CL, Deane KH, Brady MC, Smith CH, Sackley CM, Clarke CE (2012) Comparison of speech and language therapy techniques for speech problems in Parkinson’s disease. Cochrane Database Syst Rev 8:CD002814 Herd CP, Tomlinson CL, Deane KH, Brady MC, Smith CH, Sackley CM, Clarke CE (2012) Comparison of speech and language therapy techniques for speech problems in Parkinson’s disease. Cochrane Database Syst Rev 8:CD002814
17.
Zurück zum Zitat Sturkenboom IH, Graff MJ, Hendriks JC, Veenhuizen Y, Munneke M, Bloem BR, Nijhuis-van der Sanden MW, OTiP study group (2014) Efficacy of occupational therapy for patients with Parkinson’s disease: a randomised controlled trial. Lancet Neurol 13(6):557–566CrossRefPubMed Sturkenboom IH, Graff MJ, Hendriks JC, Veenhuizen Y, Munneke M, Bloem BR, Nijhuis-van der Sanden MW, OTiP study group (2014) Efficacy of occupational therapy for patients with Parkinson’s disease: a randomised controlled trial. Lancet Neurol 13(6):557–566CrossRefPubMed
18.
Zurück zum Zitat Tomlinson CL, Patel S, Meek C, Herd CP, Clarke CE, Stowe R, Shah L, Sackley C, Deane KH, Wheatley K et al (2012) Physiotherapy intervention in Parkinson’s disease: systematic review and meta-analysis. BMJ 345:e5004CrossRefPubMedPubMedCentral Tomlinson CL, Patel S, Meek C, Herd CP, Clarke CE, Stowe R, Shah L, Sackley C, Deane KH, Wheatley K et al (2012) Physiotherapy intervention in Parkinson’s disease: systematic review and meta-analysis. BMJ 345:e5004CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Oguh O, Eisenstein A, Kwasny M, Simuni T (2014) Back to the basics: regular exercise matters in Parkinson’s disease: results from the National Parkinson Foundation QII registry study. Parkinsonism Relat Disord 20(11):1221–1225CrossRefPubMed Oguh O, Eisenstein A, Kwasny M, Simuni T (2014) Back to the basics: regular exercise matters in Parkinson’s disease: results from the National Parkinson Foundation QII registry study. Parkinsonism Relat Disord 20(11):1221–1225CrossRefPubMed
20.
Zurück zum Zitat Litvan I, Goldman JG, Troster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH et al (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord 27(3):349–356CrossRefPubMedPubMedCentral Litvan I, Goldman JG, Troster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH et al (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord 27(3):349–356CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Aarsland D, Bronnick K, Fladby T (2011) Mild cognitive impairment in Parkinson’s disease. Curr Neurol Neurosci Rep 11(4):371–378CrossRefPubMed Aarsland D, Bronnick K, Fladby T (2011) Mild cognitive impairment in Parkinson’s disease. Curr Neurol Neurosci Rep 11(4):371–378CrossRefPubMed
22.
Zurück zum Zitat Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22(12):1689–1707 (quiz 1837)CrossRefPubMed Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22(12):1689–1707 (quiz 1837)CrossRefPubMed
23.
Zurück zum Zitat Aarsland D, Kurz MW (2010) The epidemiology of dementia associated with Parkinson disease. J Neurol Sci 289(1–2):18–22CrossRefPubMed Aarsland D, Kurz MW (2010) The epidemiology of dementia associated with Parkinson disease. J Neurol Sci 289(1–2):18–22CrossRefPubMed
24.
Zurück zum Zitat Goldman JG, Weintraub D (2015) Advances in the treatment of cognitive impairment in Parkinson’s disease. Mov Disord 30(11):1471–1489CrossRefPubMed Goldman JG, Weintraub D (2015) Advances in the treatment of cognitive impairment in Parkinson’s disease. Mov Disord 30(11):1471–1489CrossRefPubMed
26.
Zurück zum Zitat Bahar-Fuchs A, Clare L, Woods B (2013) Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia. Cochrane Database Syst Rev 6:CD003260 Bahar-Fuchs A, Clare L, Woods B (2013) Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia. Cochrane Database Syst Rev 6:CD003260
27.
Zurück zum Zitat Folkerts A‑K, Kalbe E. Kognitive Interventionen zur Therapie kognitiver Störungen bei Morbus Parkinson: ein praxisorientierter Überblick. Fortschr Neurol Psychiatr 84 (Suppl 1):S24–35 Folkerts A‑K, Kalbe E. Kognitive Interventionen zur Therapie kognitiver Störungen bei Morbus Parkinson: ein praxisorientierter Überblick. Fortschr Neurol Psychiatr 84 (Suppl 1):S24–35
28.
Zurück zum Zitat Leung IH, Walton CC, Hallock H, Lewis SJ, Valenzuela M, Lampit A (2015) Cognitive training in Parkinson disease: A systematic review and meta-analysis. Neurology 85(21):1843–1851CrossRefPubMedPubMedCentral Leung IH, Walton CC, Hallock H, Lewis SJ, Valenzuela M, Lampit A (2015) Cognitive training in Parkinson disease: A systematic review and meta-analysis. Neurology 85(21):1843–1851CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Kalbe E, Folkerts A‑K (2016) Kognitives Training bei Parkinson-Patienten – eine neue Therapieoption? Fortschr Neurol Psychiatr 84:S24–S35CrossRefPubMed Kalbe E, Folkerts A‑K (2016) Kognitives Training bei Parkinson-Patienten – eine neue Therapieoption? Fortschr Neurol Psychiatr 84:S24–S35CrossRefPubMed
30.
Zurück zum Zitat Diez-Cirarda M, Ojeda N, Pena J, Cabrera-Zubizarreta A, Lucas-Jimenez O, Gomez-Esteban JC, Gomez-Beldarrain MA, Ibarretxe-Bilbao N (2016) Increased brain connectivity and activation after cognitive rehabilitation in Parkinson’s disease: a randomized controlled trial. Brain Imaging Behav. doi:10.1007/s11682-016-9639-x PubMed Diez-Cirarda M, Ojeda N, Pena J, Cabrera-Zubizarreta A, Lucas-Jimenez O, Gomez-Esteban JC, Gomez-Beldarrain MA, Ibarretxe-Bilbao N (2016) Increased brain connectivity and activation after cognitive rehabilitation in Parkinson’s disease: a randomized controlled trial. Brain Imaging Behav. doi:10.​1007/​s11682-016-9639-x PubMed
31.
Zurück zum Zitat Fox SH, Katzenschlager R, Lim SY, Ravina B, Seppi K, Coelho M, Poewe W, Rascol O, Goetz CG, Sampaio C (2011) The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson’s disease. Mov Disord 26(Suppl 3):S2–S41CrossRefPubMed Fox SH, Katzenschlager R, Lim SY, Ravina B, Seppi K, Coelho M, Poewe W, Rascol O, Goetz CG, Sampaio C (2011) The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson’s disease. Mov Disord 26(Suppl 3):S2–S41CrossRefPubMed
32.
Zurück zum Zitat Fasano A, Daniele A, Albanese A (2012) Treatment of motor and non-motor features of Parkinson’s disease with deep brain stimulation. Lancet Neurol 11(5):429–442CrossRefPubMed Fasano A, Daniele A, Albanese A (2012) Treatment of motor and non-motor features of Parkinson’s disease with deep brain stimulation. Lancet Neurol 11(5):429–442CrossRefPubMed
33.
Zurück zum Zitat Deuschl G, Paschen S, Witt K (2013) Clinical outcome of deep brain stimulation for Parkinson’s disease. Handb Clin Neurol 116C:107–128CrossRef Deuschl G, Paschen S, Witt K (2013) Clinical outcome of deep brain stimulation for Parkinson’s disease. Handb Clin Neurol 116C:107–128CrossRef
34.
Zurück zum Zitat Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schafer H, Botzel K, Daniels C, Deutschlander A, Dillmann U, Eisner W et al (2006) A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med 355(9):896–908CrossRefPubMed Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schafer H, Botzel K, Daniels C, Deutschlander A, Dillmann U, Eisner W et al (2006) A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med 355(9):896–908CrossRefPubMed
35.
Zurück zum Zitat Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, Marks WJ Jr., Rothlind J, Sagher O, Moy C et al (2010) Pallidal versus subthalamic deep-brain stimulation for Parkinson’s disease. N Engl J Med 362(22):2077–2091CrossRefPubMed Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, Marks WJ Jr., Rothlind J, Sagher O, Moy C et al (2010) Pallidal versus subthalamic deep-brain stimulation for Parkinson’s disease. N Engl J Med 362(22):2077–2091CrossRefPubMed
36.
Zurück zum Zitat Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, Bottacchi E, Cannas A, Ceravolo G, Ceravolo R et al (2009) The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 24(11):1641–1649CrossRefPubMed Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, Bottacchi E, Cannas A, Ceravolo G, Ceravolo R et al (2009) The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 24(11):1641–1649CrossRefPubMed
37.
Zurück zum Zitat Chaudhuri KR, Healy DG, Schapira AH (2006) Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 5(3):235–245CrossRefPubMed Chaudhuri KR, Healy DG, Schapira AH (2006) Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 5(3):235–245CrossRefPubMed
38.
Zurück zum Zitat Erasmi R, Deuschl G, Witt K (2014) Deep brain stimulation for Parkinson’s disease: timing and patient selection. Nervenarzt 85(2):137–146CrossRefPubMed Erasmi R, Deuschl G, Witt K (2014) Deep brain stimulation for Parkinson’s disease: timing and patient selection. Nervenarzt 85(2):137–146CrossRefPubMed
39.
Zurück zum Zitat Volkmann J, Daniels C, Witt K (2010) Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease. Nat Rev Neurol 6(9):487–498PubMed Volkmann J, Daniels C, Witt K (2010) Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease. Nat Rev Neurol 6(9):487–498PubMed
40.
Zurück zum Zitat Thobois S, Ardouin C, Lhommee E, Klinger H, Lagrange C, Xie J, Fraix V, Coelho Braga MC, Hassani R, Kistner A et al (2010) Non-motor dopamine withdrawal syndrome after surgery for Parkinson’s disease: predictors and underlying mesolimbic denervation. Brain 133(Pt 4):1111–1127CrossRefPubMed Thobois S, Ardouin C, Lhommee E, Klinger H, Lagrange C, Xie J, Fraix V, Coelho Braga MC, Hassani R, Kistner A et al (2010) Non-motor dopamine withdrawal syndrome after surgery for Parkinson’s disease: predictors and underlying mesolimbic denervation. Brain 133(Pt 4):1111–1127CrossRefPubMed
41.
Zurück zum Zitat Thobois S, Lhommee E, Klinger H, Ardouin C, Schmitt E, Bichon A, Kistner A, Castrioto A, Xie J, Fraix V et al (2013) Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil. Brain 136(Pt 5):1568–1577CrossRefPubMed Thobois S, Lhommee E, Klinger H, Ardouin C, Schmitt E, Bichon A, Kistner A, Castrioto A, Xie J, Fraix V et al (2013) Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil. Brain 136(Pt 5):1568–1577CrossRefPubMed
42.
Zurück zum Zitat Chung CL, Mak MK (2016) Effect of repetitive transcranial magnetic stimulation on physical function and motor signs in Parkinson’s disease: A systematic review and meta-analysis. Brain Stimul 9(4):475–487CrossRefPubMed Chung CL, Mak MK (2016) Effect of repetitive transcranial magnetic stimulation on physical function and motor signs in Parkinson’s disease: A systematic review and meta-analysis. Brain Stimul 9(4):475–487CrossRefPubMed
43.
Zurück zum Zitat Lefaucheur JP, Antal A, Ayache SS, Benninger DH, Brunelin J, Cogiamanian F, Cotelli M, De Ridder D, Ferrucci R, Langguth B et al (2016) Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS). Clin Neurophysiol 128(1):56–92CrossRefPubMed Lefaucheur JP, Antal A, Ayache SS, Benninger DH, Brunelin J, Cogiamanian F, Cotelli M, De Ridder D, Ferrucci R, Langguth B et al (2016) Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS). Clin Neurophysiol 128(1):56–92CrossRefPubMed
44.
Metadaten
Titel
Nichtmedikamentöse Therapieverfahren beim Morbus Parkinson
verfasst von
Prof. Dr. K. Witt
E. Kalbe
R. Erasmi
G. Ebersbach
Publikationsdatum
01.03.2017
Verlag
Springer Medizin
Erschienen in
Der Nervenarzt / Ausgabe 4/2017
Print ISSN: 0028-2804
Elektronische ISSN: 1433-0407
DOI
https://doi.org/10.1007/s00115-017-0298-y

Weitere Artikel der Ausgabe 4/2017

Der Nervenarzt 4/2017 Zur Ausgabe

Mitteilungen der DGN

Mitteilungen der DGN

Mitteilungen der DSG

Mitteilungen der DSG